The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

詳細情報 詳細情報について

• CRID

  1360861294725691776

• DOI

  10.3389/fimmu.2020.574271

• ISSN

  16643224

• Web Site

  https://www.frontiersin.org/article/10.3389/fimmu.2020.574271/full

• データソース種別

  • Crossref